Form 4: Lemaitre Vascular Inc. Executive Awarded Stock Options and Restricted Stock Units

Sentiment:

Executive Compensation Filing


Lemaitre Vascular Inc. has granted stock options and restricted stock units to Senior Vice President of Operations, Trent G. Kamke.

Summary

  • Lemaitre Vascular Inc. granted stock options and restricted stock units to Trent G. Kamke, Senior Vice President of Operations, on December 6, 2024.
  • The stock options allow Kamke to purchase 5,444 shares at a price of $101.12.
  • These options vest over a four-year period, with 25% vesting on the first anniversary of the grant date and the remainder vesting in equal annual installments over the following three years.
  • Kamke also received 5,321 restricted stock units, which vest over a four-year period.
  • 25% of the restricted stock units vest on the anniversary of the grant date, with the balance vesting in equal annual installments over the remaining three years.
  • The restricted stock unit award includes a provision for the company to withhold shares to cover taxes due on each vesting date.

Sentiment

Score: 7

Explanation: The document reflects a standard practice of executive compensation, which is generally positive for aligning management and shareholder interests. There are no indications of negative sentiment.

Positives

  • The granting of stock options and restricted stock units can serve as an incentive for the Senior VP of Operations to perform well.
  • The vesting schedule encourages long-term commitment from the executive.

Risks

  • The value of the stock options is dependent on the future performance of the company's stock price.
  • The company will need to withhold shares to cover taxes due on vesting, which could dilute the overall shareholding.

Future Outlook

The vesting schedule for the stock options and restricted stock units is designed to incentivize long-term performance and retention of the executive.

Industry Context

Granting stock options and restricted stock units is a common practice in the corporate world to align the interests of executives with those of shareholders and to incentivize performance.

Comparison to Industry Standards

  • The vesting schedule of 25% on the first anniversary and the remainder over three years is a fairly standard practice for stock options and restricted stock units.
  • Many companies in the medical device industry use similar equity-based compensation plans to attract and retain key talent.

Stakeholder Impact

  • Shareholders may view this as a positive move to incentivize management.
  • The executive is incentivized to improve company performance to increase the value of their stock options and restricted stock units.

Next Steps

  • The stock options and restricted stock units will vest according to the specified schedule.
  • The company will withhold shares to cover taxes due on vesting.

Key Dates

DateDescription
2024-12-06Grant date for stock options and restricted stock units.
2024-12-10Date of signature on the filing.
2031-12-06End of the vesting period for the stock options and restricted stock units.

Keywords

stock options, restricted stock units, executive compensation, vesting, Lemaitre Vascular Inc., LMAT, equity awards

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.